MACHINE LEARNING APPROACHES FOR PREDICTING DRUG-TARGET INTERACTIONS AND BIOACTIVITY

Authors

  • Dr. Samuel K. Hartman Department of Molecular Medicine, Institute of Biomedical Research, USA

Keywords:

drug-target interaction; drug-target affinity; bioactivity prediction; machine learning; graph neural network; transformer; molecular representation; virtual screening; explainable AI.

Abstract

Machine-learning methods have become central to computational drug discovery because they can prioritize likely drug-target interactions (DTIs), estimate continuous binding affinity, and predict compound bioactivity before expensive experimental testing. This article reviews and systematizes contemporary machine-learning approaches for DTI and bioactivity prediction within an IMRAD framework. Public resources such as BindingDB and ChEMBL, benchmark datasets including Davis and KIBA, and molecular-property benchmarks such as MoleculeNet were considered together with representative methods ranging from classical descriptor-based models to convolutional networks, graph neural networks, transformers, domain-adaptation methods, and pretrained chemical/protein language models. The synthesis indicates that model performance is driven not only by architecture but also by data curation, representation choice, negative-sample construction, split strategy, calibration, and applicability-domain control. Graph-based and transformer-based methods improve representation learning, while pretrained language models broaden the ability to transfer across chemical and protein sequence spaces. However, random pair splitting can markedly overestimate prospective performance when related drugs or targets appear in both training and test sets. Consequently, scaffold-aware drug-cold, target-cold, cold-both, and temporal validation are increasingly important for credible translation. The article proposes an integrated evaluation framework that combines predictive accuracy, calibration, uncertainty, interpretability, and prospective generalization. Machine learning should therefore be treated as a prioritization layer that complements, rather than replaces, experimental pharmacology.

 

References

1. Liao, Q., Zhang, Y., Chu, Y., Ding, Y., Liu, Z., Zhao, X., Wang, Y., Wan, J., Ding, Y., Tiwari, P., Zou, Q., & Han, K. (2025). Application of artificial intelligence in drug-target interactions prediction: A review. npj Biomedical Innovations, 2, 1. https://doi.org/10.1038/s44385-024-00003-9

2. Ozturk, H., Ozgur, A., & Ozkirimli, E. (2018). DeepDTA: Deep drug-target binding affinity prediction. Bioinformatics, 34(17), i821-i829. https://doi.org/10.1093/bioinformatics/bty593

3. Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S. (2021). GraphDTA: Predicting drug-target binding affinity with graph neural networks. Bioinformatics, 37(8), 1140-1147. https://doi.org/10.1093/bioinformatics/btaa921

4. Huang, K., Xiao, C., Glass, L. M., & Sun, J. (2021). MolTrans: Molecular Interaction Transformer for drug-target interaction prediction. Bioinformatics, 37(6), 830-836. https://doi.org/10.1093/bioinformatics/btaa880

5. Yang, Z., Zhong, W., Zhao, L., & Chen, C. Y.-C. (2022). MGraphDTA: Deep multiscale graph neural network for explainable drug-target binding affinity prediction. Chemical Science, 13(3), 816-833. https://doi.org/10.1039/D1SC05180F

6. Abbasi, K., Razzaghi, P., Poso, A., Amanlou, M., Ghasemi, J. B., & Masoudi-Nejad, A. (2020). DeepCDA: Deep cross-domain compound-protein affinity prediction through LSTM and convolutional neural networks. Bioinformatics, 36(17), 4633-4642. https://doi.org/10.1093/bioinformatics/btaa544

7. Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T. (2015). Toward more realistic drug-target interaction predictions. Briefings in Bioinformatics, 16(2), 325-337. https://doi.org/10.1093/bib/bbu010

8. Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018). MoleculeNet: A benchmark for molecular machine learning. Chemical Science, 9(2), 513-530. https://doi.org/10.1039/C7SC02664A

9. Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., Palmer, A., Settels, V., Jaakkola, T., Jensen, K., & Barzilay, R. (2019). Analyzing learned molecular representations for property prediction. Journal of Chemical Information and Modeling, 59(8), 3370-3388. https://doi.org/10.1021/acs.jcim.9b00237

10. Heid, E., Greenman, K. P., Chung, Y., Li, S.-C., Graff, D. E., Vermeire, F. H., Wu, H., Green, W. H., & McGill, C. J. (2024). Chemprop: A machine learning package for chemical property prediction. Journal of Chemical Information and Modeling, 64(1), 9-17. https://doi.org/10.1021/acs.jcim.3c01250

11. Graff, D. E., Morgan, N. K., Burns, J. W., Doner, A. C., Li, B., Li, S.-C., Manu, J., Menon, A., Pang, H.-W., Wu, H., Zalte, A. S., Zheng, J. W., Coley, C. W., Green, W. H., & Greenman, K. P. (2026). Chemprop v2: An efficient, modular machine learning package for chemical property prediction. Journal of Chemical Information and Modeling, 66(1), 28-33. https://doi.org/10.1021/acs.jcim.5c02332

12. Gilson, M. K., Liu, T., Baitaluk, M., Nicola, G., Hwang, L., & Chong, J. (2016). BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology. Nucleic Acids Research, 44(D1), D1045-D1053. https://doi.org/10.1093/nar/gkv1072

13. Bento, A. P., Gaulton, A., Hersey, A., Bellis, L. J., Chambers, J., Davies, M., Kruger, F. A., Light, Y., Mak, L., McGlinchey, S., Nowotka, M., Papadatos, G., Santos, R., & Overington, J. P. (2014). The ChEMBL bioactivity database: An update. Nucleic Acids Research, 42(D1), D1083-D1090. https://doi.org/10.1093/nar/gkt1031

14. Li, X., Yang, Q., Luo, G., et al. (2023). SAGDTI: Self-attention and graph neural network with multiple information representations for the prediction of drug-target interactions. Bioinformatics Advances, 3(1), vbad116. https://doi.org/10.1093/bioadv/vbad116

15. Bidgoli, A. H., Mahdavi, M., & Malek, H. (2026). Structure-free drug-target affinity prediction using protein and molecule language models. Journal of Cheminformatics, 18, 21. https://doi.org/10.1186/s13321-025-01146-6

Published

2026-09-21